Conference Coverage

Early-onset preeclampsia more likely to occur in women with lupus


 

ACR ANNUAL MEETING

– Women with systemic lupus erythematosus are nine times more likely to develop early-onset preeclampsia during a first pregnancy than are women without the disease, according a study of two Swedish national population-based registries.

The risk of preeclampsia occurring before 34 weeks’ gestation declined with subsequent pregnancies, but it remained significantly elevated above the background risk, Julia F. Simard, ScD, said at the annual meeting of the American College of Rheumatology.

preeclampsia copyright Sohel_Parvez_Haque/Thinkstock
In the study, Dr. Simard of Stanford (Calif.) University and the Karolinska Institute, Stockholm, and her colleagues matched births from women with systemic lupus erythematosus (SLE) and healthy women without the disease in Sweden during 2001-2012 in the Swedish Medical Birth Register, which captures 98% of births, and the National Patient Register, which tracks both inpatient and outpatient visits. The final risk model was adjusted for patient age, pregestational hypertension, pregestational diabetes, and smoking.

During the study period, 742 births to women with SLE were matched with 10,484 births to women without the disease. The mean age of the patients was 31 years.

Of the women with SLE, 5% had pregestational hypertension and 3% had pregestational diabetes. Antiphospholipid antibodies were present in 2%. Among the controls, less than 1% had pregestational hypertension, and 1.3% had pregestational diabetes. There were no healthy controls with antiphospholipid antibodies.

In the entire cohort, there were 438 cases of preeclampsia: 82 in the SLE group and 356 in the control group. In the fully adjusted model, this translated to nearly a tripling of relative risk (RR, 2.7).

Preeclampsia more commonly occurred in first births, based on 56 cases in the SLE group and 225 in the control group. SLE patients in their first pregnancy also had a tripling of risk (RR, 3.2). Among subsequent births, there were 157 cases: 26 in the SLE group and 131 in the control group. The relative risk for preeclampsia was lower, but still significantly elevated (RR, 2).

There were 87 cases of early-onset preeclampsia: 32 in the SLE group and 55 in the control group. Women with SLE were more than six times more likely to develop the disorder (RR, 6.3). Early-onset preeclampsia was more common in first births for both groups: 24 in the SLE group and 34 in the control group, for a ninefold increased risk (RR, 9.3).

Again, the incidence decreased with subsequent births in both groups: 8 cases in the SLE group and 21 in the control group. But SLE patients still faced a significant threefold increase in risk (RR, 2.8).

“Antiphospholipid antibodies appear to be an important risk factor that needs to more fully understood,” Dr. Simard said. “But the risk seems to be independent of other traditional risk factors, like pregestational hypertension, body mass index, and smoking.”

She and her associates had no financial disclosures.

On Twitter @alz_gal

Recommended Reading

In lupus, optimize non-immunosuppressives to dial back prednisone
MDedge Internal Medicine
Severe joint pain in adults with arthritis continues to rise
MDedge Internal Medicine
Tryptase gene variant linked to GI, joint, and skin symptoms
MDedge Internal Medicine
Riociguat shows benefit in PAH with poor response to PDE inhibitors
MDedge Internal Medicine
New criteria estimate systemic sclerosis to be more prevalent in primary biliary cholangitis patients
MDedge Internal Medicine
Tocilizumab makes big impression in giant cell arteritis treatment
MDedge Internal Medicine
VIDEO: Biologics: Proposed guideline addresses perioperative management
MDedge Internal Medicine
AURA-LV study: Rapid remission with voclosporin for lupus nephritis
MDedge Internal Medicine
Myeloablative HSCT bests IV CYC for systemic scleroderma
MDedge Internal Medicine
Low-dose IL-2 shows promise for refractory lupus
MDedge Internal Medicine